Research published in JACC: Heart Failure Nov. 6 uncovered a worrying statistic in cardiology: Older patients who are hospitalized for heart failure could experience as much as a 12% increase in the number of HF-exacerbating medications they’re prescribed between admission and hospital discharge.

Living with chronic stress could have serious implications for blood pressure control in black patients, Reuters reported Nov. 5.

A study out of the University of Pennsylvania School of Nursing suggests that weight loss achieved through a combination of intensive behavioral therapy and 3 milligrams of liraglutide daily results in optimal weight-related quality of life for patients struggling with obesity.

Edwards Lifesciences announced Nov. 6 that it had received expanded CE mark approval in Europe for the use of its SAPIEN 3 transcatheter heart valve, a tool designed to facilitate TAVI in patients who don’t want to undergo open-heart surgery.

A novel risk calculator developed by researchers at the Cleveland Clinic encourages patients with both type 2 diabetes and obesity to weigh their treatment options for optimal long-term health.

A study published in Hypertension this month has found that exercise—historically one of our best first-line defenses against cardiovascular disease—could also negatively impact heart health in certain situations, including at work.

A cross-sectional study of heart patients undergoing ICD implantation revealed a marked decline in the use of defibrillation testing over time in the U.S., suggesting the precaution might be losing its value as a clinical tool.

Two studies reach conflicting conclusions while underscoring the need for best practice guidelines to fill the current vacuum.